{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:15:29Z","timestamp":1772745329368,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024253","name":"Western Australian Future Health and Innovation Fund, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001799","name":"Murdoch University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019111","name":"Perron Institute for Neurological and Translational Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022560","name":"Spinnaker Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jaut.2023.103150","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T14:53:02Z","timestamp":1701528782000},"page":"103150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DR\u03b21 chain"],"prefix":"10.1016","volume":"142","author":[{"given":"Nataliya","family":"Slater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Sooda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"McLeish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Brusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bundell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank L.","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrilee","family":"Needham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6081-8494","authenticated-orcid":false,"given":"Jerome D.","family":"Coudert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaut.2023.103150_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103150_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JND-160198","article-title":"A systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis","volume":"4","author":"Callan","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"issue":"9","key":"10.1016\/j.jaut.2023.103150_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp.2007.138891","article-title":"Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases","volume":"79","author":"Needham","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"6","key":"10.1016\/j.jaut.2023.103150_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/BOR.0000000000000327","article-title":"Epidemiology of sporadic inclusion body myositis","volume":"28","author":"\u00d8","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103150_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13311-015-0394-2","article-title":"Immunotherapies for immune-mediated myopathies: a current perspective","volume":"13","author":"Needham","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.jaut.2023.103150_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jaut.2023.103150_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken","volume":"129","author":"Benveniste","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jaut.2023.103150_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fimmu.2019.00745","article-title":"Anti-NT5c1A autoantibodies as biomarkers in inclusion body myositis","volume":"10","author":"Amlani","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2023.103150_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2014-310008","article-title":"Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement","volume":"87","author":"Goyal","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jaut.2023.103150_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mus.24199","article-title":"Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: isotypes and diagnostic utility","volume":"50","author":"Greenberg","year":"2014","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jaut.2023.103150_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","article-title":"Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","volume":"75","author":"Herbert","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2023.103150_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jaut.2023.103150_bib13","first-page":"314","article-title":"Construction of a genetic linkage map in man using restriction fragment length polymorphisms","volume":"32","author":"Botstein","year":"1980","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jaut.2023.103150_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0198-8859(92)90023-G","article-title":"Ancestral haplotypes: conserved population MHC haplotypes","volume":"34","author":"Degli-Esposti","year":"1992","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103150_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","article-title":"HLA associations with inclusion body myositis","volume":"98","author":"Garlepp","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2023.103150_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0039.2004.00310.x","article-title":"Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3","volume":"64","author":"Price","year":"2004","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1016\/j.jaut.2023.103150_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians","volume":"84","author":"O'Hanlon","year":"2005","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.jaut.2023.103150_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2011.02.011","article-title":"Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex","volume":"235","author":"Scott","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.jaut.2023.103150_bib19","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2023.103150_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(97)00245-2","article-title":"HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies","volume":"84","author":"Koffman","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103150_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2012.05.003","article-title":"High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes","volume":"250","author":"Rojana-udomsart","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.jaut.2023.103150_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00415-003-0204-3","article-title":"Analysis of HLA class I and II alleles in sporadic inclusion-body myositis","volume":"250","author":"Lampe","year":"2003","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jaut.2023.103150_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.40045","article-title":"Immune-array analysis in sporadic inclusion body myositis reveals HLA-DRB1 amino acid heterogeneity across the myositis spectrum","volume":"69","author":"Rothwell","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.jaut.2023.103150_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008177","article-title":"Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV","volume":"15","author":"Currenti","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2023.103150_bib25","first-page":"D948","article-title":"IPD\u2010IMGT\/HLA database","volume":"48","author":"Robinson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2023.103150_bib26","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.pathol.2016.12.327","article-title":"Diagnostic utility of cytoplasmic 5\u2019-nucleotidase autoantibodies to identify inclusion body myositis patients","volume":"49","author":"Bundell","year":"2017","journal-title":"Pathology"},{"issue":"7","key":"10.1016\/j.jaut.2023.103150_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009131","article-title":"MiDAS-meaningful immunogenetic data at scale","volume":"17","author":"Migdal","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"61","key":"10.1016\/j.jaut.2023.103150_bib28","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: the'ggstatsplot'approach","volume":"6","author":"Patil","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.jaut.2023.103150_bib29","series-title":"A Language and Environment for Statistical Computing","author":"Team","year":"2021"},{"issue":"11","key":"10.1016\/j.jaut.2023.103150_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nmd.2009.07.015","article-title":"Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype","volume":"19","author":"Mastaglia","year":"2009","journal-title":"Neuromuscul. Disord. : NMD"},{"issue":"8","key":"10.1016\/j.jaut.2023.103150_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","article-title":"Benefits and limitations of genome-wide association studies","volume":"20","author":"Tam","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"14","key":"10.1016\/j.jaut.2023.103150_bib32","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/hmg\/ddac019","article-title":"Association with HLA-DR\u03b21 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis","volume":"31","author":"Deakin","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.jaut.2023.103150_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","article-title":"Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups","volume":"78","author":"Rothwell","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2023.103150_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.jaut.2023.103150_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gene.6364059","article-title":"Arginine at position 74 of the HLA-DR [beta]1 chain is associated with Graves' disease","volume":"5","author":"Ban","year":"2004","journal-title":"Gene Immun."},{"issue":"39","key":"10.1016\/j.jaut.2023.103150_bib36","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1073\/pnas.1009511107","article-title":"Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis","volume":"107","author":"Menconi","year":"2010","journal-title":"Proceedings of the National Academy of Sciences - PNAS"},{"issue":"3","key":"10.1016\/j.jaut.2023.103150_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gene.6364059","article-title":"Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease","volume":"5","author":"Ban","year":"2004","journal-title":"Gene Immun."},{"issue":"2","key":"10.1016\/j.jaut.2023.103150_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101661","article-title":"Genetics and epigenetics of autoimmune thyroid diseases: Translational implications","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103150_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s42003-022-03717-x","article-title":"The lupus susceptibility allele DRB103:01 encodes a disease-driving epitope","volume":"5","author":"Miglioranza Scavuzzi","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jaut.2023.103150_bib40","first-page":"14","article-title":"Uncovering the significance of expanded CD8 + large granular lymphocytes in inclusion body myositis: insights into T cell phenotype and functional alterations, and disease severity","author":"McLeish","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2023.103150_bib41","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","author":"Greenberg","year":"2019","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jaut.2023.103150_bib42","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class i and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2023.103150_bib43","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.immuni.2016.09.015","article-title":"Antiviral CD8+ T cells restricted by human leukocyte antigen class II exist during natural HIV infection and exhibit clonal expansion","volume":"45","author":"Ranasinghe","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2023.103150_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46462-8","article-title":"HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers","volume":"9","author":"Nyanhete","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jaut.2023.103150_bib45","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41590-019-0448-4","article-title":"A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44","volume":"20","author":"Niehrs","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jaut.2023.103150_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jneuroim.2012.09.003","article-title":"Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis","volume":"254","author":"Rojana-udomsart","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103150_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.176.2.327","article-title":"Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens","volume":"176","author":"Baixeras","year":"1992","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.jaut.2023.103150_bib48","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4 + T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2023.103150_bib49","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1128\/JVI.00406-12","article-title":"A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection","volume":"86","author":"Thomas","year":"2012","journal-title":"J. Virol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:33:04Z","timestamp":1760257984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"alternative-id":["S0896841123001592"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103150","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DR\u03b21 chain","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103150"}}